Intravitreal diclofenac may improve visual acuity in eyes with macular edema due to BRVO

Intravitreal diclofenac may improve best corrected visual acuity and decrease central macular thickness in eyes with macular edema related to branch retinal vein occlusion, a study found.In the prospective study, 15 eyes of 15 patients received a single 500 µg/0.1 mL intravitreal dose of diclofenac injected with a 27-gauge needle in the inferotemporal quadrant 3.5 mm posterior to the limbus in pseudophakic eyes and 4 mm posterior to the limbus in phakic eyes.

Senate bill focuses on development of genetically targeted drugs

The U.S. Senate is considering a bipartisan bill intended to speed up the development of genetically targeted drugs for patients with rare life-threatening or debilitating conditions.The Advancing Targeted Therapies for Rare Diseases Act of 2015 (S. 2030) would “allow the sponsor of an application for the approval of a targeted drug to rely upon data and information with respect to such sponsor’s previously approved targeted drugs.”

Senate bill focuses on development of genetically targeted drugs

The U.S. Senate is considering a bipartisan bill intended to speed up the development of genetically targeted drugs for patients with rare life-threatening or debilitating conditions.The Advancing Targeted Therapies for Rare Diseases Act of 2015 (S. 2030) would “allow the sponsor of an application for the approval of a targeted drug to rely upon data and information with respect to such sponsor’s previously approved targeted drugs.”